QQQ   423.39 (-0.58%)
AAPL   166.67 (-0.79%)
MSFT   406.63 (-1.27%)
META   504.11 (+2.01%)
GOOGL   156.53 (+0.68%)
AMZN   179.10 (-1.20%)
TSLA   149.80 (-3.63%)
NVDA   845.59 (+0.62%)
AMD   154.23 (+0.14%)
NIO   4.03 (+3.07%)
BABA   68.96 (+0.20%)
T   16.21 (+0.56%)
F   12.02 (-0.17%)
MU   112.99 (-2.87%)
GE   154.25 (-0.91%)
CGC   8.06 (+24.19%)
DIS   112.91 (-0.03%)
AMC   2.87 (-3.69%)
PFE   25.29 (-0.51%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)
QQQ   423.39 (-0.58%)
AAPL   166.67 (-0.79%)
MSFT   406.63 (-1.27%)
META   504.11 (+2.01%)
GOOGL   156.53 (+0.68%)
AMZN   179.10 (-1.20%)
TSLA   149.80 (-3.63%)
NVDA   845.59 (+0.62%)
AMD   154.23 (+0.14%)
NIO   4.03 (+3.07%)
BABA   68.96 (+0.20%)
T   16.21 (+0.56%)
F   12.02 (-0.17%)
MU   112.99 (-2.87%)
GE   154.25 (-0.91%)
CGC   8.06 (+24.19%)
DIS   112.91 (-0.03%)
AMC   2.87 (-3.69%)
PFE   25.29 (-0.51%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)
QQQ   423.39 (-0.58%)
AAPL   166.67 (-0.79%)
MSFT   406.63 (-1.27%)
META   504.11 (+2.01%)
GOOGL   156.53 (+0.68%)
AMZN   179.10 (-1.20%)
TSLA   149.80 (-3.63%)
NVDA   845.59 (+0.62%)
AMD   154.23 (+0.14%)
NIO   4.03 (+3.07%)
BABA   68.96 (+0.20%)
T   16.21 (+0.56%)
F   12.02 (-0.17%)
MU   112.99 (-2.87%)
GE   154.25 (-0.91%)
CGC   8.06 (+24.19%)
DIS   112.91 (-0.03%)
AMC   2.87 (-3.69%)
PFE   25.29 (-0.51%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)
QQQ   423.39 (-0.58%)
AAPL   166.67 (-0.79%)
MSFT   406.63 (-1.27%)
META   504.11 (+2.01%)
GOOGL   156.53 (+0.68%)
AMZN   179.10 (-1.20%)
TSLA   149.80 (-3.63%)
NVDA   845.59 (+0.62%)
AMD   154.23 (+0.14%)
NIO   4.03 (+3.07%)
BABA   68.96 (+0.20%)
T   16.21 (+0.56%)
F   12.02 (-0.17%)
MU   112.99 (-2.87%)
GE   154.25 (-0.91%)
CGC   8.06 (+24.19%)
DIS   112.91 (-0.03%)
AMC   2.87 (-3.69%)
PFE   25.29 (-0.51%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cronos Group Inc. stock logo
CRON
Cronos Group
$2.39
-1.2%
$2.32
$1.64
$2.99
$913.00M1.172.88 million shs3.17 million shs
Tilray Inc stock logo
TLRY
Tilray
$1.75
+1.5%
$1.96
$1.50
$3.40
$1.30B2.3629.53 million shs22.84 million shs
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$43.30
+0.7%
$47.95
$42.59
$69.60
$833.09M0.9179,888 shs29,978 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cronos Group Inc. stock logo
CRON
Cronos Group
-0.82%-7.28%+8.52%+23.47%+18.63%
Tilray Inc stock logo
TLRY
Tilray
-6.01%-14.85%-10.42%-11.34%-30.36%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
-0.37%-5.43%-12.04%-9.47%-32.77%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cronos Group Inc. stock logo
CRON
Cronos Group
1.6858 of 5 stars
2.25.00.00.03.30.01.3
Tilray Inc stock logo
TLRY
Tilray
1.2952 of 5 stars
3.12.00.00.02.20.01.3
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
3.7297 of 5 stars
2.34.00.03.01.31.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cronos Group Inc. stock logo
CRON
Cronos Group
2.33
Hold$2.8318.55% Upside
Tilray Inc stock logo
TLRY
Tilray
2.25
Hold$2.7155.21% Upside
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
2.50
Moderate Buy$48.0010.85% Upside

Current Analyst Ratings

Latest TLRY, USNA, and CRON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
Tilray Inc stock logo
TLRY
Tilray
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy$4.25 ➝ $4.00
4/10/2024
Tilray Inc stock logo
TLRY
Tilray
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$2.25 ➝ $2.00
4/8/2024
Cronos Group Inc. stock logo
CRON
Cronos Group
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$2.00 ➝ $2.50
4/5/2024
Tilray Inc stock logo
TLRY
Tilray
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral$2.25 ➝ $2.75
2/22/2024
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$53.00 ➝ $48.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cronos Group Inc. stock logo
CRON
Cronos Group
$87.24M10.47N/AN/A$2.87 per share0.83
Tilray Inc stock logo
TLRY
Tilray
$627.12M2.07$0.00 per share2,016.22$4.50 per share0.39
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$921.01M0.90$4.41 per share9.81$25.99 per share1.67

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cronos Group Inc. stock logo
CRON
Cronos Group
-$73.96M-$0.19N/A79.67N/A-84.15%-3.99%-3.87%5/14/2024 (Estimated)
Tilray Inc stock logo
TLRY
Tilray
-$1.45B-$0.44N/AN/AN/A-43.98%-2.68%-2.09%7/24/2024 (Estimated)
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$63.79M$3.3013.1213.831.326.93%13.49%10.45%4/30/2024 (Confirmed)

Latest TLRY, USNA, and CRON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024N/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$0.69N/A-$0.69N/AN/AN/A  
2/29/2024Q4 2023
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A-$0.05-$0.05$0.02$25.15 million$23.92 million    
2/6/2024Q4 2023
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$0.52$0.87+$0.35$0.87$206.70 million$221.08 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
N/AN/AN/AN/AN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
22.54
21.81
Tilray Inc stock logo
TLRY
Tilray
0.11
1.92
1.18
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
N/A
3.52
3.00

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
Tilray Inc stock logo
TLRY
Tilray
9.35%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
54.25%

Insider Ownership

CompanyInsider Ownership
Cronos Group Inc. stock logo
CRON
Cronos Group
1.96%
Tilray Inc stock logo
TLRY
Tilray
0.68%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
0.33%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
356382.01 million374.52 millionOptionable
Tilray Inc stock logo
TLRY
Tilray
1,600742.72 million737.67 millionOptionable
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
1,80019.24 million19.18 millionOptionable

TLRY, USNA, and CRON Headlines

SourceHeadline
USANA Health Sciences (NYSE:USNA) Reaches New 1-Year Low at $43.83USANA Health Sciences (NYSE:USNA) Reaches New 1-Year Low at $43.83
americanbankingnews.com - April 14 at 5:50 AM
USANA Health Sciences (NYSE:USNA) Sets New 12-Month Low at $43.83USANA Health Sciences (NYSE:USNA) Sets New 12-Month Low at $43.83
marketbeat.com - April 12 at 3:59 PM
USANA Schedules First Quarter 2024 Earnings Release and Conference CallUSANA Schedules First Quarter 2024 Earnings Release and Conference Call
businesswire.com - April 10 at 4:15 PM
USANA Cements Itself as a Premier Cellular Nutrition Company in South KoreaUSANA Cements Itself as a Premier Cellular Nutrition Company in South Korea
prnewswire.com - April 9 at 9:08 AM
USANA Health Sciences, Inc. (NYSE:USNA) has caught the attention of institutional investors who hold a sizeable 49% stakeUSANA Health Sciences, Inc. (NYSE:USNA) has caught the attention of institutional investors who hold a sizeable 49% stake
finance.yahoo.com - April 8 at 4:46 PM
Vanguard Group Inc. Has $91.85 Million Stock Position in USANA Health Sciences, Inc. (NYSE:USNA)Vanguard Group Inc. Has $91.85 Million Stock Position in USANA Health Sciences, Inc. (NYSE:USNA)
marketbeat.com - April 6 at 4:14 AM
Kevin Guest Says This Spring Cultivate a Growth Mindset: The Essential Soft Skill for Business Success in 2024Kevin Guest Says This Spring Cultivate a Growth Mindset: The Essential Soft Skill for Business Success in 2024
finance.yahoo.com - April 2 at 8:04 AM
USANA Health Sciences, Inc. (NYSE:USNA) Stock Holdings Increased by Pacer Advisors Inc.USANA Health Sciences, Inc. (NYSE:USNA) Stock Holdings Increased by Pacer Advisors Inc.
marketbeat.com - March 27 at 6:12 AM
Some Investors May Be Worried About USANA Health Sciences (NYSE:USNA) Returns On CapitalSome Investors May Be Worried About USANA Health Sciences' (NYSE:USNA) Returns On Capital
finance.yahoo.com - March 25 at 1:14 PM
USNA Apr 2024 45.000 putUSNA Apr 2024 45.000 put
finance.yahoo.com - March 16 at 3:38 PM
USANA Health Sciences, Inc. (NYSE:USNA) COO Walter Noot Sells 5,240 SharesUSANA Health Sciences, Inc. (NYSE:USNA) COO Walter Noot Sells 5,240 Shares
insidertrades.com - March 12 at 5:01 AM
Usana Health Sciences Inc (USNA) Executive Chairman of the Board Kevin Guest Sells 11,011 SharesUsana Health Sciences Inc (USNA) Executive Chairman of the Board Kevin Guest Sells 11,011 Shares
finance.yahoo.com - March 11 at 9:34 PM
Usana Health Sciences Inc (USNA) Chief Scientific Officer Robert Sinnott Sells Company SharesUsana Health Sciences Inc (USNA) Chief Scientific Officer Robert Sinnott Sells Company Shares
finance.yahoo.com - March 6 at 6:45 PM
Usana Health Sciences Incs Chief Legal Officer Joshua Foukas Sells Company SharesUsana Health Sciences Inc's Chief Legal Officer Joshua Foukas Sells Company Shares
finance.yahoo.com - March 4 at 5:35 PM
Kevin Guest Says Leap Forward on Leap DayKevin Guest Says Leap Forward on Leap Day
prnewswire.com - February 28 at 7:03 AM
USANA Sustainability and DEI Executive Director Awarded in UtahUSANA Sustainability and DEI Executive Director Awarded in Utah
prnewswire.com - February 22 at 9:47 AM
Jim Simons Adjusts Position in Usana Health Sciences IncJim Simons Adjusts Position in Usana Health Sciences Inc
finance.yahoo.com - February 14 at 4:28 AM
USANA Health Sciences Full Year 2023 Earnings: EPS Beats ExpectationsUSANA Health Sciences Full Year 2023 Earnings: EPS Beats Expectations
finance.yahoo.com - February 8 at 9:57 AM
USANA Health Sciences, Inc. (NYSE:USNA) Q4 2023 Earnings Call TranscriptUSANA Health Sciences, Inc. (NYSE:USNA) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 8 at 9:57 AM
USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat EstimatesUSANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates
finance.yahoo.com - February 7 at 12:08 AM
Usana Health Sciences Inc (USNA) Reports Mixed Fiscal Year 2023 ResultsUsana Health Sciences Inc (USNA) Reports Mixed Fiscal Year 2023 Results
finance.yahoo.com - February 6 at 7:08 PM
USANA Health Sciences Q4 Income Climbs, Beats estimatesUSANA Health Sciences Q4 Income Climbs, Beats estimates
markets.businessinsider.com - February 6 at 7:08 PM
USANA (NYSE:USNA) Q4 Sales Beat EstimatesUSANA (NYSE:USNA) Q4 Sales Beat Estimates
finance.yahoo.com - February 6 at 7:08 PM
Kevin Guest Calls on All to Connect during February Month of FriendshipKevin Guest Calls on All to Connect during February Month of Friendship
finance.yahoo.com - February 1 at 9:45 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Cronos Group logo

Cronos Group

NASDAQ:CRON
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Tilray logo

Tilray

NASDAQ:TLRY
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.
USANA Health Sciences logo

USANA Health Sciences

NYSE:USNA
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.